Evaluation of the Satisfaction of Patients Coming "on Foot" in the Operating Room
Bloc3D
1 other identifier
observational
300
1 country
5
Brief Summary
Ambulatory surgery is currently experiencing unprecedented growth and is becoming the standard of care compared to traditional hospitalization. Without mentioning the obvious financial gains, the benefits of ambulatory care essentially lie in optimised perioperative comfort. This comfort is due to a limited period of stay (\< 12 hours) and to the proactive action of the care providers. In this context, the optimization of the whole patient's journey during the perioperative period has been reviewed and adapted to personalized management within healthcare facilities. For more than a year now, multimodal approaches such as early rehabilitation have been undertaken, including
- morning admission with an innovative principle of "3D" patient (standing, dignified, relaxed)
- no premedication, wearing glasses and wigs,
- Drinking on the morning of the intervention (2H before admission),
- Walking to the block on foot (or in a wheelchair), return adapted to the wheelchair and no longer in a stretcher,
- fast resumption of feeding. Currently, in the investigator's various institutions, several modes of transport to the operating theatres coexist. The purpose of this observational study is to evaluate this optimization of perioperative management "3D mode", in particular the mode of transport. The main objective is to determine the level of patient satisfaction with this management using a standardized quality questionnaire: the "EVAN" questionnaire. This questionnaire contains 22 items allowing a global analysis of patient satisfaction. This questionnaire is already routinely conducted in many institutions. The EVAN questionnaire will be supplemented by questionnaires assessing the level of perioperative anxiety. They will be initiated into the anesthesia consultation, and finalized on the day of the surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2019
Shorter than P25 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 25, 2019
CompletedFirst Submitted
Initial submission to the registry
January 27, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2020
CompletedFirst Posted
Study publicly available on registry
July 1, 2020
CompletedAugust 4, 2021
August 1, 2021
1 year
January 27, 2020
August 3, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Satisfaction of day case surgery: EVAN-G score
Satisfaction is measured with an EVAN-G score (1-100 points)
Day 0
Study Arms (2)
operating block admission "on foot"
Patient going to the oparating block on foot
standard operating block admission
Patient going to the operating room in a conventional way (stretcher)
Interventions
Patient satisfaction evaluated with EVAN G questionnaire
Eligibility Criteria
The patients included in the study are patients at least 18 years old, hospitalized for scheduled surgery, who have accepted the principle of the study, are able to complete the EVAN-G questionnaire and are able to walk alone.
You may qualify if:
- Age \> 18 yars
- Consent to participate
You may not qualify if:
- Emergency surgery
- ASA \>4
- Difficulties in French reading, incapacity to complete questionnaire
- patient in a wheelchair or stretcher or having difficulty walking alone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
CHU Nimes
Nîmes, Gard, 30 000, France
Clinique Juge
Marseille, 13000, France
Institut paoli Calmette
Marseille, 13000, France
Chu Montpellier - Saint-Eloi
Montpellier, 34295, France
Institut de cancerologie de Montpellier
Montpellier, 34295, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Blandine Fayard, MD
CHU Nimes, France
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 27, 2020
First Posted
July 1, 2020
Study Start
February 25, 2019
Primary Completion
February 28, 2020
Study Completion
February 28, 2020
Last Updated
August 4, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share